期刊文献+
共找到277篇文章
< 1 2 14 >
每页显示 20 50 100
Endoscopic Management of Severe Supraglottic and Posterior Glottic Stenosis Due to Chemotherapy and Radiation
1
作者 Shaina M. Rubino Michael J. Pitman 《International Journal of Otolaryngology and Head & Neck Surgery》 2014年第3期133-136,共4页
Combined posterior and supraglottic stenosis (CS) often presents as debilitating dysphonia or dyspnea, secondary to blunt trauma or traumatic intubation. However, CS has proven to be a late complication of chemoradiat... Combined posterior and supraglottic stenosis (CS) often presents as debilitating dysphonia or dyspnea, secondary to blunt trauma or traumatic intubation. However, CS has proven to be a late complication of chemoradiation therapy. Traditional treatment of combined posterior and supraglottic stenosis (CS) secondary to chemoradiation has been frequently complicated by poor tissue healing. This case study illustrates a novel endoscopic surgical technique employing a large laterally-based flap as a posterior glottic keel by rotating it anteroinferiorly and suturing it in place. As a result of the procedure, the bilateral vocal folds, which were midline and immobile preoperatively, regained normal motion. The supraglottic airway was also restored. Successful endoscopic treatment of CS with bilateral vocal fold immobility is possible using a large laterally-based flap, even in the face of tissue changes secondary to chemoradiation. 展开更多
关键词 POSTERIOR glottic STENOSIS SUPRAglottic STENOSIS Combined glottic STENOSIS RADIATION ENDOSCOPIC Surgery
下载PDF
Clinical Outcome of Definitive Radiotherapy and/or Surgery in T1-2N0M0 Glottic Squamous Cell Carcinoma: A Single Institution Retrospective Report
2
作者 Dina Ragab Diab Ibrahim Anas Mohamed Askoura Mohammed Aleem 《Journal of Cancer Therapy》 2018年第2期163-178,共16页
Background: The current treatment options of early glottic carcinoma are radiotherapy;trans laser microsurgery, and open surgery. However, the best treatment is still controversial due to lack of randomized controlled... Background: The current treatment options of early glottic carcinoma are radiotherapy;trans laser microsurgery, and open surgery. However, the best treatment is still controversial due to lack of randomized controlled trials. We aimed to evaluate the treatment results and the prognostic factors of local control of early glottic squamous cell carcinoma patients (GSCC) T1-2N0M0 treated at our institution. Material and Methods: We retrospectively studied the charts of 52 patients with early GSCC T1-T2N0M0 from 2010-2015 at the Clinical Oncology Department, Ain-Shams University. 24 patients had T1 and 28 had T2 early glottic carcinoma. The overall survival OS, local control rate, and laryngeal preservation rate were evaluated. Kaplan-Meier method, Cox proportional hazards model were used to analyze the data. Results: Median duration of follow-up was 13 months. Thirty-eight patients received radiation treatment alone (73.1%), 7.7% of the patients underwent surgery alone, and 19.2% of the patients had surgery combined with radiotherapy. Local recurrence after radiation failure developed in 6/52 patients, all had T2 disease and were salvaged by total laryngectomy. The ultimate local control rate was 88.5%, and the ultimate laryngeal preservation rate was 77.2% (40/52 patients). The median OS of the 52 patients was 13 months (range 2 - 46 months). Univariate analysis of factors associated with poor local control showed that age > 60 years was the only significant factor (P = 0.048). Conclusion: Radiotherapy achieves high local control and laryngeal preservation rates for patients with early glottic carcinoma, and is associated with a low rate of severe complications compared to surgery. Salvage surgery is feasible after radiotherapy failure. 展开更多
关键词 LARYNX glottic SQUAMOUS Cell Carcinoma Outcome Radiotherapy SURGERY
下载PDF
Radiotherapy and Chemotherapy in T2N0 Glottic Cancer: Does Chemotherapy Improve Local Control?
3
作者 Takashi Kosugi Kazunori Suzuki +2 位作者 Kenta Konishi Hotaka Nonaka Hiroyuki Mineta 《Journal of Cancer Therapy》 2013年第2期513-517,共5页
Purpose: To compare concurrent chemoradiotherapy with radiotherapy in T2N0 glottic cancer. Materials and Methods: Thirty nine patients were treated with radiotherapy alone. In detail, 30 patients treated between 1985 ... Purpose: To compare concurrent chemoradiotherapy with radiotherapy in T2N0 glottic cancer. Materials and Methods: Thirty nine patients were treated with radiotherapy alone. In detail, 30 patients treated between 1985 and 1995, and 9 patients treated between 1995 and 2010 were included in the radiotherapy alone group. Between 1995 and 2010, 22 patients were treated with concurrent chemoradiotherapy. Conventional fractionation was applied in 19 patients in the radiotherapy group and in 1 patient in the chemoradiotherapy group. Hyperfractionation was applied to 20 patients in the radiotherapy group and to 21 patients in the chemoradiotherapy group. Total dose ranged from 64 Gy to 76.8 Gy in the radiotherapy group and from 66 Gy to 76.8 Gy in the chemoradiotherapy group. Cisplatin or carboplatin was administered in the chemoradiotherapy group. Results: There were no differences in the 5-year preservation rate of vocal function (82.8% vs 87.4%, p = 0.652), local control rate (77.2% vs 92.9%, p = 0.163), and 5-year overall survival rate (86.4% vs 90.2%, p = 0.497) between the radiotherapy and chemoradiotherapy groups. Conclusion: In T2N0 glottic cancer, no difference was observed between radiotherapy alone and concurrent chemoradiotherapy groups. 展开更多
关键词 T2 glottic Cancer Radiation Therapy CHEMOTHERAPY VOICE PRESERVATION Local Control
下载PDF
An Analysis of the Global and Partial Voice Handicap Index in Patients with Early Glottic Carcinoma Treated with High Level of Irradiation
4
作者 Daniela Musio Francesca De Felice +6 位作者 Cristina Bigelli Nadia Bulzonetti Roberta Guarnaccia Mario Tombolini Giovanni Ruoppolo Marco de Vincentiis Vincenzo Tombolini 《Journal of Cancer Therapy》 2014年第1期21-27,共7页
Background: This is a retrospective study on a group of patients with early glottic carcinoma, treated with curative radiotherapy. The aim of the study is to assess voice quality after treatment. We also evaluated loc... Background: This is a retrospective study on a group of patients with early glottic carcinoma, treated with curative radiotherapy. The aim of the study is to assess voice quality after treatment. We also evaluated local recurrence, overall survival, disease free survival and toxicity. Material and Methods: We examined a total of 36 patients, out of which 27 were smokers: 10 females/5 smokers;26 males/22 smokers. The sample was observed from January 2007 to July 2012 (average follow-up period: 33.5 months, range 12 - 76). Diagnosis of early glottic carcinoma was eight during the two-year period 2007/2008, nine during 2009/2010, eleven during year 2011 and eight during year 2012. All patients suffering from early glottic carcinoma, histopathologically confirmed, were classified as follows: 24 patients T1a, 3 patients T1b, 6 patients T2 and 3 patients had a carcinoma in situ. They were treated only with conventional radiotherapy. After the treatment (total dose 70 Gy), patients were asked to fill out the Voice Handicap Index (VHI) questionnaire, composed of 30 questions that covered physical, emotional and functional areas. Results: The global VHI was evidenced with good voice quality (62% of patients: VHI < 30;34% of patients: VHI 31 - 60). Vocal disability was mild in over 70% of patients within the physical area and over 80% within the emotional area. We observed two local recurrences, one occurred five years after the end of radiation therapy and one six months after. In terms of toxicity, we observed that acute reactions, such as dysphonia, dysphagia and erythema, were relatively limited. Conclusions: The VHI index suggests that radiotherapy produces acceptable functional results, with limited repercussion on life quality. In line with literature, our data confirmed good cure rates and larynx preservation (94.4%). 展开更多
关键词 glottic CARCINOMA VOICE HANDICAP Index RADIOTHERAPY
下载PDF
A Combination of Endoscopic CO<sub>2</sub>Laser Microsurgery and Radiotherapy for Treatment of T2N0M0 Glottic Carcinoma
5
作者 Motohiro Sawatsubashi Toshiro Umezaki +1 位作者 Takemoto Shin Shizuo Komune 《International Journal of Otolaryngology and Head & Neck Surgery》 2012年第2期28-33,共6页
The aims of this study were to evaluate the results of CO2 laser surgery alone and CO2 laser surgery combined with radiotherapy in patients with T2N0M0 glottic carcinoma. A retrospective analysis was conducted of 35 c... The aims of this study were to evaluate the results of CO2 laser surgery alone and CO2 laser surgery combined with radiotherapy in patients with T2N0M0 glottic carcinoma. A retrospective analysis was conducted of 35 cases of T2N0M0 glottic carcinoma. Fourteen patients with normal vocal cord mobility were treated with endoscopic CO2 laser surgery alone. The remaining 21 patients were treated with CO2 laser surgery followed by radiotherapy (44 - 70 Gy, including low-dose carboplatin chemoradiotherapy). Main outcome measures were local control, organ preservation, recurrence, 5-year survival, and successful salvage in cases of recurrence. We evaluated the patient’s voice with the psychoacoustics GRBAS scale, maximum phonation time (MPT), and airflow rate (AFR) obtained by aerodynamic tests. Mean follow-up period was 5 years. Among the 35 T2N0M0 patients, 5-year survival and 5-year voice preservation rates were 97% and 89%, respectively. Local recurrence occurred in 7 of these patients (20%);4 of 7 local recurrences were successfully re-treated by laser surgery. Total laryngectomy was necessary for salvage treatment in the remaining 3 patients. The post-treatment voice qualities were judged to be the same or improved over pretreatment qualities. There was little change in MPT and AFR after treatment in non-recurrence patients. CO2 laser microsurgery is an excellent tool for treating selected cases of T2N0M0 展开更多
关键词 T2 glottic Carcinoma Laryngeal Cancer ENDOSCOPIC LASER Surgery CHEMORADIOTHERAPY
下载PDF
A self-fused hydrogel for the treatment of glottic insufficiency through outstanding durability,extracellular matrix-inducing bioactivity and function preservation
6
作者 Chen-Yu Zou Juan-Juan Hu +8 位作者 Dan Lu Qian-Jin Li Yan-Lin Jiang Rui Wang Hai-Yang Wang Xiong-Xin Lei Jesse Li-Ling Hui Yang Hui-Qi Xie 《Bioactive Materials》 SCIE CSCD 2023年第6期54-68,共15页
Injection laryngoplasty with biomaterials is an effective technique to treat glottic insufficiency.However,the inadequate durability,deficient pro-secretion of extracellular matrix(ECM)and poor functional preservation... Injection laryngoplasty with biomaterials is an effective technique to treat glottic insufficiency.However,the inadequate durability,deficient pro-secretion of extracellular matrix(ECM)and poor functional preservation of current biomaterials have yielded an unsatisfactory therapeutic effect.Herein,a self-fusing bioactive hydrogel comprising modified carboxymethyl chitosan and sodium alginate is developed through a dual-crosslinking mechanism(photo-triggered and dynamic covalent bonds).Owing to its characteristic networks,the synergistic effect of the hydrogel for vocal folds(VFs)vibration and phonation is adequately demonstrated.Notably,owing to its inherent bioactivity of polysaccharides,the hydrogel could significantly enhance the secretion of major components(type I/III collagen and elastin)in the lamina propria of the VFs both in vivo and in vitro.In a rabbit model for glottic insufficiency,the optimized hydrogel(C1A1)has demonstrated a durability far superior to that of the commercially made hyaluronic acid(HA)Gel.More importantly,owing to the ECM-inducing bioactivity,the physiological functions of the VFs treated with the C1A1 hydrogel also outperformed that of the HA Gel,and were similar to those of the normal VFs.Taken together,through a simple-yet-effective strategy,the novel hydrogel has demonstrated outstanding durability,ECM-inducing bioactivity and physiological function preservation,therefore has an appealing clinical value for treating glottic insufficiency. 展开更多
关键词 glottic insufficiency Self-fusion HYDROGEL Extracellular matrix Physiological function
原文传递
BURP手法在改善声门视野中的应用
7
作者 梁汉生 冯艺 杨拔贤 《临床麻醉学杂志》 CAS CSCD 北大核心 2024年第9期971-973,共3页
直接喉镜解决困难气管插管时,BURP手法能改善声门视野,提高插管成功率,但也有研究表明BURP手法会使声门视野恶化。随着视频喉镜的广泛应用,BURP手法的临床价值再次引起争议。本文就BURP手法的定义、方法、基本原理、应用喉镜时改善声门... 直接喉镜解决困难气管插管时,BURP手法能改善声门视野,提高插管成功率,但也有研究表明BURP手法会使声门视野恶化。随着视频喉镜的广泛应用,BURP手法的临床价值再次引起争议。本文就BURP手法的定义、方法、基本原理、应用喉镜时改善声门视野的作用等方面进行综述,以期为解决困难气管插管提供参考。 展开更多
关键词 喉镜检查 BURP手法 气管插管 困难气道 声门视野
下载PDF
血清CC型趋化因子2、CC型趋化因子18与声门型喉癌患者临床病理参数和预后的关系
8
作者 武川军 要兆旭 +3 位作者 冯志星 马海滨 刘琳 段晓辉 《中国耳鼻咽喉头颈外科》 CSCD 2024年第9期554-558,579,共6页
目的研究血清CC型趋化因子2(CC type chemotactic factor 2,CCL2)、CCL18与声门型喉癌患者临床病理参数和预后的关系。方法选择邯郸市中心医院和河北工程大学附属医院2015年8月~2018年12月收治的168例声门型喉癌患者为研究对象,受试者... 目的研究血清CC型趋化因子2(CC type chemotactic factor 2,CCL2)、CCL18与声门型喉癌患者临床病理参数和预后的关系。方法选择邯郸市中心医院和河北工程大学附属医院2015年8月~2018年12月收治的168例声门型喉癌患者为研究对象,受试者工作特征(ROC)曲线确定血清CCL2、CCL18最佳截点,将患者分为CCL2高表达组和低表达组、CCL18高表达组和低表达组,分析血清CCL2、CCL18水平与声门型喉癌患者临床病理参数的关系,采用Kaplan-Meier曲线和Log-Rankχ^(2)检验分析血清CCL2高表达组和低表达组、CCL18高表达组和低表达组的5年无病生存率,采用Cox回归模型分析声门型喉癌预后的影响因素,并分析血清CCL2和CCL18表达与肿瘤复发/转移的关系。结果根据ROC曲线计算得出CCL2、CCL18的最佳截点分别为100.81、218.99 pg/ml。相较于CCL2、CCL18低表达组,CCL2、CCL18高表达组T3~T4a级、N1~N3级、肿瘤低分化占比明显升高(P<0.05)。168例声门型喉癌患者随访5年失访8例,完成随访160例。67例发生复发/转移,39例因复发/转移而死亡,肿瘤复发/转移率为41.88%(67/160),无病生存率为58.13%(93/160)。Kaplan-Meier生存曲分析显示,血清CCL2、CCL18高表达组5年无病生存率均明显低于血清CCL2、CCL18低表达组(P<0.05)。Cox回归分析显示,T分级升高、颈淋巴结复发、N分级升高、咽喉部复发、CCL2高表达、CCL18高表达是声门型喉癌预后不良的危险因素(P<0.05)。分析血清CCL2和CCL18表达与肿瘤复发/转移的关系发现,CCL2和CCL18均高表达时其复发/转移率明显高于CCL2和CCL18均低表达、CCL2低表达且CCL18高表达、CCL2高表达且CCL18低表达,差异比较有统计学意义(χ^(2)=10.450,P=0.015)。结论声门型喉癌患者血清CCL2、CCL18高表达与T分级、N分级、肿瘤低分化和预后不良显著相关。 展开更多
关键词 喉肿瘤 预后 CC型趋化因子2 CC型趋化因子18 声门型喉癌 临床病理参数
下载PDF
早期声门型喉癌的治疗进展
9
作者 陈曦 陆兆屹 《中国耳鼻咽喉颅底外科杂志》 CAS CSCD 2024年第3期1-8,共8页
声门型喉癌占喉癌发病的70%,淋巴结转移少见。早期声门型喉癌常常引起声音嘶哑,就诊过程中,易于早期发现,在所有喉癌中预后最好。近10年来美国国家综合癌症网络(NCCN)指南中关于早期声门型喉癌的诊治经历20余次的更新,已逐步形成经口内... 声门型喉癌占喉癌发病的70%,淋巴结转移少见。早期声门型喉癌常常引起声音嘶哑,就诊过程中,易于早期发现,在所有喉癌中预后最好。近10年来美国国家综合癌症网络(NCCN)指南中关于早期声门型喉癌的诊治经历20余次的更新,已逐步形成经口内镜下CO_(2)激光手术或单纯放疗为主的治疗模式。喉功能保留和嗓音质量是衡量治疗成功与否的关键因素,目前开放手术的应用越来越少,而首选CO_(2)激光手术还是单纯放射治疗方案的问题一直是悬而未决的。本文将分别介绍早期声门型喉癌的治疗进展及个性化治疗选择的关键要点,并总结影响肿瘤复发的预后因素及预测复发的生物学标志物,以期为指导早期声门型喉癌患者的治疗及随访提供临床参考。 展开更多
关键词 早期声门型喉癌 治疗 复发 个性化
下载PDF
低温等离子刀治疗早期声门型喉癌的疗效分析
10
作者 薛建亭 《中外医疗》 2024年第21期61-64,共4页
目的探讨低温等离子刀治疗早期声门型喉癌患者的效果。方法回顾性选取2021年6月—2023年6月单县中心医院耳鼻咽喉科收治的80例早期声门型喉癌患者的临床资料,根据不同的手术方式分组,将其分为对照组(n=40)和研究组(n=40),对照组实施传... 目的探讨低温等离子刀治疗早期声门型喉癌患者的效果。方法回顾性选取2021年6月—2023年6月单县中心医院耳鼻咽喉科收治的80例早期声门型喉癌患者的临床资料,根据不同的手术方式分组,将其分为对照组(n=40)和研究组(n=40),对照组实施传统手术治疗,研究组实施低温等离子刀治疗,对比两组手术指标和术后康复情况、嗓音功能及并发症的发生情况。结果研究组手术时间(15.61±2.50)min短于对照组(35.21±5.47)min,术中出血量(10.54±2.12)mL少于对照组(18.95±2.34)mL,黏膜恢复评分(2.07±0.48)分低于对照组(3.69±0.57)分,住院时间(8.20±1.35)d短于对照组(15.17±2.42)d,差异有统计学意义(t=20.611、16.845、13.749、15.907,P均<0.05)。研究组的振幅微扰和基频微扰低于对照组,谐噪比高于对照组,差异有统计学意义(P均<0.05)。研究组并发症总发生率[5.00%(2/40)]低于对照组[20.00%(8/40)],差异有统计学意义(χ^(2)=4.114,P<0.05)。结论实施低温等离子刀治疗的效果较为理想,值得在后续临床中应用。 展开更多
关键词 低温等离子刀 早期声门型喉癌 手术指标 嗓音功能 并发症
下载PDF
胸骨舌骨肌内翻喉功能重建术对声门型喉癌的疗效分析
11
作者 苗文杰 王慧敏 +2 位作者 周航 鲁保才 连荣 《实用临床医药杂志》 CAS 2024年第17期41-44,50,共5页
目的 观察胸骨舌骨肌内翻喉功能重建术对声门型喉癌的疗效。方法 选择2020年1月—2023年12月本院耳鼻咽喉科收治的106例声门型喉癌患者为研究对象,将其随机分成对照组与观察组,每组53例。对照组行垂直部分喉切除术,观察组行垂直部分喉... 目的 观察胸骨舌骨肌内翻喉功能重建术对声门型喉癌的疗效。方法 选择2020年1月—2023年12月本院耳鼻咽喉科收治的106例声门型喉癌患者为研究对象,将其随机分成对照组与观察组,每组53例。对照组行垂直部分喉切除术,观察组行垂直部分喉切除术联合胸骨舌骨肌内翻喉功能重建术。观察2组嗓音学指标[标准化噪声能量(NNE)、谐噪比(HNR)、基频微扰(Jitter)、振幅微扰(Shimmer)]、吞咽功能[电视透视吞咽功能检查(VFSS)评分]、生活质量[嗓音障碍指数(VHI)评分]、发音功能改善情况以及并发症(刺激性咳嗽、咽痛、呼吸困难、喉狭窄、局部粘连)发生情况。结果 2组术后3个月的NNE、Jitter、Shimmer均较术前下降,HNR提高,差异有统计学意义(P<0.05);观察组术后3个月的NNE、Jitter、Shimmer低于对照组,HNR高于对照组,差异有统计学意义(P<0.05)。2组术后3个月VFSS评分较术前提高,VHI评分较术前降低,差异有统计学意义(P<0.05);观察组术后3个月的VFSS评分高于对照组,VHI评分低于对照组,差异有统计学意义(P<0.05)。对照组发音功能改善效果优良率为71.70%,低于观察组的88.68%,差异有统计学意义(P<0.05)。观察组并发症发生率为9.43%,低于对照组的24.53%,差异有统计学意义(P<0.05)。结论 垂直部分喉切除术联合胸骨舌骨肌内翻喉功能重建术治疗声门型喉癌,可有效改善患者嗓音学指标、吞咽功能、生活质量以及发音功能,且并发症发生率较低。 展开更多
关键词 胸骨舌骨肌内翻喉功能重建术 声门型喉癌 嗓音学指标 吞咽功能 生活质量 发音功能 并发症
下载PDF
Lemierre综合征患者机械通气撤机后继发声门闭合不全的护理
12
作者 周飞飞 高春华 林燕 《中华急危重症护理杂志》 CSCD 2024年第1期47-50,共4页
总结1例Lemierre综合征患者机械通气撤机后继发声门闭合不全的护理体会。针对患者撤机难度大,再插管风险高等问题,采取急性期呼吸支持;拔管前风险评估、多学科制订拔管策略、拔管后观察与应急处置;预警评估,平衡出血与血栓,积极控制感染... 总结1例Lemierre综合征患者机械通气撤机后继发声门闭合不全的护理体会。针对患者撤机难度大,再插管风险高等问题,采取急性期呼吸支持;拔管前风险评估、多学科制订拔管策略、拔管后观察与应急处置;预警评估,平衡出血与血栓,积极控制感染,预防交叉感染;阶段性康复训练,目标导向营养支持及正性心理支持等措施。经过25 d积极治疗与护理,患者病情好转,转康复医院继续治疗。随访3个月,患者生活恢复正常。 展开更多
关键词 Lemierre综合征 声门闭合不全 通气机撤除法 危重病护理
下载PDF
T_(1b)声门型喉癌的治疗现状
13
作者 刘鑫 吕元景 项丞 《现代肿瘤医学》 CAS 2024年第4期774-777,共4页
声门型喉癌治疗方式的选择决定着患者的生存质量和预后,T_(1b)声门型喉癌有多种治疗方式,各方式有不同的优势与不足,本文综述T_(1b)声门型喉癌的治疗现状。
关键词 T_(1b)声门型喉癌 经口激光显微手术 放射治疗 开放性部分喉切除术 低温等离子射频消融
下载PDF
3种不同术式治疗累及前联合的早期声门型喉癌临床疗效分析
14
作者 胡陈芮 胡煜 +2 位作者 汪涛 代键 刘丛利 《安徽医学》 2024年第5期565-569,共5页
目的比较3种不同术式治疗累及前联合的早期声门型喉癌的临床疗效,为临床治疗术式的选择提供参考。方法回顾性分析2014年3月至2022年3月六安市人民医院耳鼻咽喉头颈外科收住的累及前联合的早期声门型喉癌患者76例,根据手术治疗方式的不同... 目的比较3种不同术式治疗累及前联合的早期声门型喉癌的临床疗效,为临床治疗术式的选择提供参考。方法回顾性分析2014年3月至2022年3月六安市人民医院耳鼻咽喉头颈外科收住的累及前联合的早期声门型喉癌患者76例,根据手术治疗方式的不同,分为等离子组(采用支撑喉镜显微镜下低温等离子喉部分切除术治疗,27例)、开放组(采用开放式喉部分切除术治疗,27例)和CO_(2)激光组(采用支撑喉镜显微镜下CO_(2)激光喉部分切除术治疗,22例)。比较3组手术相关指标、术后并发症及复发率差异。结果3组手术时间、术中出血量、术后住院时间及黏膜恢复评分比较,差异有统计学意义(P<0.05);两两比较显示,等离子组与开放组的差异、CO_(2)激光组与开放组的差异均有统计学意义(P<0.05),等离子组与CO_(2)激光组上述指标比较,差异均无统计学意义(P=0.581、0.482、0.647、0.198)。3组术后并发症发生率比较,差异无统计学意义(P=0.384)。开放组和等离子组术后复发率低于CO_(2)激光组,差异具有统计学意义(P=0.004、0.016)。结论对于累及前联合的早期声门型喉癌患者采用支撑喉镜显微镜下低温等离子喉部分切除术治疗,具有手术时间短、创伤小、术后恢复更快、复发率低的优势,是临床治疗中值得选择的一种术式。 展开更多
关键词 早期声门型喉癌 喉部分切除术 低温等离子射频消融术 激光
下载PDF
等离子射频消融术与CO_(2)激光治疗早期声门型喉癌的效果比较 被引量:1
15
作者 洪伟 刘慧娟 苏武 《癌症进展》 2024年第4期385-388,共4页
目的比较等离子射频消融术与CO_(2)激光治疗早期声门型喉癌(EGC)的效果。方法根据治疗方法的不同将80例EGC患者分为对照组(n=40,CO_(2)激光)与研究组(n=40,等离子射频消融术),比较两组患者的围手术期指标[手术时间、术中出血量、术后住... 目的比较等离子射频消融术与CO_(2)激光治疗早期声门型喉癌(EGC)的效果。方法根据治疗方法的不同将80例EGC患者分为对照组(n=40,CO_(2)激光)与研究组(n=40,等离子射频消融术),比较两组患者的围手术期指标[手术时间、术中出血量、术后住院时间、术后24 h视觉模拟评分法(VAS)评分]、嗓音功能[振幅微扰、谐噪比(HNR)、基频微扰]、生活质量[嗓音障碍指数(VHI)]、吞咽功能[电视透视吞咽功能检查(VFSS)]、局部复发情况及并发症发生情况。结果研究组患者手术时间、术后住院时间均明显短于对照组,术中出血量明显少于对照组,术后24 h VAS评分明显低于照组,差异均有统计学意义(P﹤0.01)。术后4周,两组患者HNR均高于本组术前,基频微扰、振幅微扰均低于本组术前,研究组患者HNR高于对照组,基频微扰、振幅微扰均低于对照组,差异均有统计学意义(P﹤0.05)。术后6个月,两组患者VHI评分均低于本组术前,VFSS评分均高于本组术前,研究组患者VHI评分低于对照组,VFSS评分高于对照组,差异均有统计学意义(P﹤0.05)。研究患者的局部复发率和并发症总发生率均低于对照组,但差异均无统计学意义(P﹥0.05)。结论与CO_(2)激光相比,等离子射频消融术治疗EGC的效果更好,可以缩短手术时间,减少术中出血量,减轻术后疼痛感,同时对患者嗓音、吞咽功能的影响较小,可以促进患者术后快速康复,并且提高生活质量。 展开更多
关键词 早期声门型喉癌 CO_(2)激光 等离子射频消融术 治疗效果
下载PDF
支撑喉镜下低温等离子射频消融术治疗早期声门型喉癌的临床疗效分析
16
作者 陈祖鸿 蔡章 黄冬冬 《中国现代药物应用》 2024年第20期42-44,共3页
目的对支撑喉镜下低温等离子射频消融术治疗早期声门型喉癌患者的效果进行观察。方法65例早期声门型喉癌患者,根据手术方法不同分为对照组(45例)和观察组(20例)。对照组患者实施常规手术治疗,观察组患者实施支撑喉镜下低温等离子射频消... 目的对支撑喉镜下低温等离子射频消融术治疗早期声门型喉癌患者的效果进行观察。方法65例早期声门型喉癌患者,根据手术方法不同分为对照组(45例)和观察组(20例)。对照组患者实施常规手术治疗,观察组患者实施支撑喉镜下低温等离子射频消融术治疗。对比两组患者的手术指标(术中出血量、手术时间、住院时间)、黏膜修复情况、视觉模拟评分法(VAS)评分、术后并发症发生率以及发音功能(基频微扰、振幅微扰以及谐噪比)。结果观察组患者术中出血量(10.28±0.86)ml少于对照组的(32.53±3.05)ml,手术时间(29.63±2.14)min、住院时间(8.18±0.78)d短于对照组的(61.24±4.55)min、(13.42±1.15)d,VAS评分(2.08±0.17)分、黏膜修复评分(2.11±0.17)分均低于对照组的(3.19±0.34)、(3.68±0.34)分(P<0.05)。观察组患者术后并发症发生率为5.00%,低于对照组的31.11%(P<0.05)。术后,观察组患者基频微扰(1.14±0.08)%、振幅微扰(4.02±0.36)%低于对照组的(1.31±0.11)%、(4.31±0.40)%,谐噪比(21.92±2.05)dB高于对照组的(20.03±1.86)dB(P<0.05)。结论在早期声门型喉癌患者治疗中,对患者实施支撑喉镜下低温等离子射频消融术,不但可以取得良好的临床治疗效果,也有助于降低患者术后并发症发生率,促进患者发音功能的恢复,值得推广。 展开更多
关键词 支撑喉镜 低温等离子射频消融术 早期声门型喉癌 疗效 发音功能
下载PDF
支撑喉镜下低温等离子射频消融术与传统喉裂开术治疗早期声门型喉癌的疗效比较
17
作者 邢金燕 谭建成 刘鑫国 《癌症进展》 2024年第14期1601-1604,共4页
目的比较支撑喉镜下低温等离子射频消融术(LPRFA)与传统喉裂开术治疗早期声门型喉癌(GC)的疗效。方法根据手术方法的不同将66例早期GC患者分为对照组(n=33,传统喉裂开术)和观察组(n=33,支撑喉镜下LPRFA)。比较两组患者的手术相关指标、... 目的比较支撑喉镜下低温等离子射频消融术(LPRFA)与传统喉裂开术治疗早期声门型喉癌(GC)的疗效。方法根据手术方法的不同将66例早期GC患者分为对照组(n=33,传统喉裂开术)和观察组(n=33,支撑喉镜下LPRFA)。比较两组患者的手术相关指标、疼痛程度[视觉模拟评分法(VAS)]、临床疗效、术后并发症发生情况、生活质量[欧洲癌症研究与治疗组织生命质量测定量表(EORTC QLQ-C30)]及复发情况。结果观察组患者的手术时间和住院时间均明显短于对照组,术中出血量明显少于对照组,差异均有统计学意义(P﹤0.01)。术后1、3天,观察组患者VAS评分均明显低于对照组,差异均有统计学意义(P﹤0.01)。观察组患者的总有效率高于对照组,术后并发症总发生率低于对照组,差异均有统计学意义(P﹤0.05)。术后3、6个月,两组患者EORTC QLQ-C30评分均高于本组术前,观察组患者EORTC QLQ-C30评分均高于对照组,差异均有统计学意义(P﹤0.05)。术后6个月,两组患者复发率比较,差异无统计学意义(P﹥0.05)。结论支撑喉镜下LPRFA治疗早期GC患者的临床疗效较好,可加快患者术后恢复,减轻术后疼痛,降低术后并发症发生率,提高生活质量。 展开更多
关键词 早期声门型喉癌 传统喉裂开术 支撑喉镜下低温等离子射频消融术 疗效 术后并发症
下载PDF
早期声门型喉癌低温等离子射频消融术的临床疗效及对患者血清VEGF、MMP-9、NO水平的影响
18
作者 王芳 张瑞芹 胡云磊 《实用癌症杂志》 2024年第10期1650-1654,共5页
目的探讨低温等离子射频消融术(RFA)在早期声门型喉癌(GC)治疗中的价值。方法选取98例早期GC患者,随机分为对照组(n=47)与观察组(n=51)。对照组予以常规喉裂开术治疗,观察组接受低温等离子RFA治疗。统计2组围术期指标、疗效、并发症发... 目的探讨低温等离子射频消融术(RFA)在早期声门型喉癌(GC)治疗中的价值。方法选取98例早期GC患者,随机分为对照组(n=47)与观察组(n=51)。对照组予以常规喉裂开术治疗,观察组接受低温等离子RFA治疗。统计2组围术期指标、疗效、并发症发生率、复发率,比较术前、术后3个月2组嗓音声学(振幅微扰、基频微扰、谐噪比)及血清基质金属蛋白酶-9(MMP-9)、血管内皮生长因子(VEGF)、一氧化氮(NO)水平。结果随访截止至2023年9月,期间对照组失访1例,未依从1例,最终纳入45例;观察组自行退出1例,失访1例,最终纳入49例。2组总有效率、复发率比较,差异无统计学意义(P>0.05)。对照组手术时间、创面上皮化时间、住院时间均长于观察组,术中出血量多于观察组(P<0.05)。术后3个月2组振幅微扰、基频微扰低于术前,谐噪比高于术前;且观察组谐噪比高于对照组,基频及振幅微扰低于对照组(P<0.05)。术后3个月2组血清MMP-9、VEGF、NO值低于术前,且观察组上述血清因子水平低于对照组(P<0.05)。对照组并发症发生率为20.00%,高于观察组的4.08%(P<0.05)。结论低温等离子RFA治疗早期GC,可优化围术期指标,改善血清MMP-9、VEGF、NO水平,促进嗓音声学恢复,降低并发症发生风险。 展开更多
关键词 早期声门型喉癌 低温等离子射频消融术 血清预后因子 嗓音声学
下载PDF
CO_(2)激光联合低温等离子射频消融术对早期声门型喉癌患者的疗效分析
19
作者 张晓明 张子梓 《实用癌症杂志》 2024年第11期1836-1839,共4页
目的探讨CO_(2)激光联合低温等离子射频消融术(LTPRFA)治疗早期声门型喉癌(EGC)患者的临床效果。方法收治EGC患者80例,按随机数字表法分为2组。对照组(n=40)采取喉部分切开手术治疗,观察组(n=40)采用CO_(2)激光联合LTPRFA治疗。比较两... 目的探讨CO_(2)激光联合低温等离子射频消融术(LTPRFA)治疗早期声门型喉癌(EGC)患者的临床效果。方法收治EGC患者80例,按随机数字表法分为2组。对照组(n=40)采取喉部分切开手术治疗,观察组(n=40)采用CO_(2)激光联合LTPRFA治疗。比较两组临床疗效、嗓音功能、疼痛程度[视觉模拟评分法(VAS)]、声带形态学评分及复发率。结果观察组临床疗效(87.50%)高于对照组(60.00%);治疗后观察组振幅微扰(2.68±0.41)%、基频微扰(1.16±0.14)%及基频(137.82±5.43)Hz均低于对照组,谐噪比(23.14±3.41)dB高于对照组,VAS评分(2.07±0.15)分低于对照组,声带形态学评分(1.14±0.12)分低于对照组,复发率(5.00%)低于对照组(22.50%),差异有统计学意义(P<0.05)。结论EGC患者采用LTPRFA治疗可取得显著疗效,利于嗓音功能恢复,减轻疼痛程度,改善声带形态学,并降低复发率。 展开更多
关键词 早期声门型喉癌 CO_(2)激光 低温等离子射频消融术 嗓音功能 疼痛程度
下载PDF
不同术式治疗T1a期声门型喉癌的嗓音功能评估 被引量:2
20
作者 王燕 屈季宁 +3 位作者 周涛 华清泉 雷薇薇 舒婧 《听力学及言语疾病杂志》 CAS CSCD 北大核心 2023年第6期509-513,共5页
目的对比CO_(2)激光、低温等离子刀切除术两种术式治疗早期声门型喉癌的嗓音恢复情况。方法回顾性分析2017年1月~2019年12月在武汉大学人民医院进行CO_(2)激光和等离子刀切除术治疗的42例T1aN0M0期声门型喉癌患者的临床资料,分为两组,A... 目的对比CO_(2)激光、低温等离子刀切除术两种术式治疗早期声门型喉癌的嗓音恢复情况。方法回顾性分析2017年1月~2019年12月在武汉大学人民医院进行CO_(2)激光和等离子刀切除术治疗的42例T1aN0M0期声门型喉癌患者的临床资料,分为两组,A组20例,采用低温等离子刀切除术治疗;B组22例,采用CO_(2)激光切除术治疗。根据病变范围,按内镜下声带切除术分类标准指南,40例患者采用Ⅲ型手术,2例采用Ⅳ型手术。术中取切缘进行冰冻病理检查,阴性即可结束手术。手术前及术后3、6、9及12个月应用嗓音障碍指数VHI-10、听感知评估GRABS及多维嗓音分析软件对患者嗓音功能进行评估,动态喉镜检查观察声带形态及黏膜波,比较两组结果。结果①两组患者术后3个月时,jitter、shimmer及NHR数值明显增高,随着时间推移,jitter、shimmer及NHR数值逐渐降低,到9个月以后,以上观察指标趋于稳定。②术后9个月时,B组嗓音功能恢复优于A组。主观听感知方面,B组术后嗓音障碍程度轻于A组;两组间jitter值差异有统计学意义(P<0.05)。③动态喉镜检查:B组术后声带闭合、运动的对称性、黏膜波、振动规律性优于A组(P<0.05)。结论对T1a期声门型喉癌患者,CO_(2)激光术后患者嗓音功能恢复情况优于低温等离子射频手术。 展开更多
关键词 声门型喉癌 CO_(2)激光 等离子刀 嗓音功能
下载PDF
上一页 1 2 14 下一页 到第
使用帮助 返回顶部